Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psilocybin for Chronic Cluster Headache
NCT04280055Phase 2Terminated
- Start
- Jan 2020
- Primary completion
- Nov 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of psilocybin in Cluster Headache (CH). Started Jan 2020; status: terminated.
02
Drugs
psilocybin
03
Conditions
Cluster Headache (CH)
Beyond the preview
Go deeper on NCT04280055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04280055.